NYSEAMERICAN:OGEN - Oragenics, Inc.
$0.60
 $-0.02
-3.23%
4:00PM EDT
2019-03-25
Oragenics, Inc. develops, markets and sells probiotics specifically designed to enhance oral health for humans and pets, under the brand names Evora and ProBiora. The Company is focused on offering antibiotics against infectious disease and on developing treatments for oral mucositis. It is engaged in developing its antibiotic product candidate, MU1140, as well as other homolog antibiotic product candidates; researching AG013 in connection with the treatment of Oral Mucositis; commercializing its ProBiora3 probiotic products, and has other product candidates for out licensing or partnering. MU1140 is an antibiotic that is produced by the parent of the SMaRT strain. ProBiora3 is a blend of three naturally occurring strains of beneficial bacteria, including Streptococcus oralis KJ3, Streptococcus uberis KJ2 and Streptococcus rattus JH145. LPT3-04 is a compound, which is consumed in the human diet in small amounts and results in dose-dependent weight loss in experimental animal models. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  OGEN     avg for
industry  
  avg for
sector  
42 stocks weight:  2. 71   0. 00   0. 00  
42 stocks rank:  3. 91 K 1. 47 K 813. 28  
# analyst opinions:  1. 00   14. 60   13. 76  
mean recommendation:  2. 00   2. 08   1. 94  

quick ratio:  8. 87   5. 02   1. 92  
current ratio:  9. 94   5. 37   2. 41  

target price low:  0. 80   86. 57   112. 35  
target price avg:  0. 80   113. 88   131. 59  
target price high:  0. 80   139. 18   151. 05  
1-yr high:  3. 57   117. 54   131. 86  
last close:  0. 60   98. 55   115. 48  
50-day avg:  0. 89   99. 18   115. 72  
200-day avg:  0. 93   97. 41   113. 92  
1-yr low:  0. 38   75. 41   92. 07  
volume:  2. 17 M 2. 47 M 4. 15 M
50-day avg volume:  1. 42 M 2. 85 M 4. 53 M
200-day avg volume:  3. 32 M 2. 93 M 4. 35 M

1-day return:  -3. 23 % 0. 22 % -0. 06 %
this week return:  -3. 23 % 0. 22 % -0. 06 %
12-wk return:  -31. 03 % 10. 73 % 9. 15 %
52-wk return:  -67. 55 % 9. 95 % 19. 39 %

enterprise value (EV):  11. 15 M 51. 84 B 103. 78 B
market cap:  17. 66 M 45. 80 B 92. 73 B
EBITDA:  -8. 55 M 4. 55 B 6. 74 B
enterprise multiple (EV/EBITDA):  -1. 30   6. 01   13. 57  
total debt:  190. 41 K 12. 38 B 16. 39 B
debt/equity:  1. 36   38. 58   85. 69  
net income (common):  -10. 03 M 2. 28 B 3. 51 B

shares outstanding:  29. 43 M 579. 54 M 1. 21 B
shares:  25. 52 M 579. 89 M 1. 18 B
shares short:  1. 66 M 9. 60 M 17. 98 M
shares short prior month:  1. 70 M 10. 48 M 11. 44 M
short ratio:  1. 65   5. 48   3. 47  
short % of float:  202. 79 % 6. 10 % 2. 53 %
total cash/share:  0. 47   11. 14   8. 46  
total cash:  13. 81 M 6. 79 B 5. 92 B
free cash flow:  -4. 12 M 3. 65 B 4. 03 B
operating cash flow:  -7. 46 M 4. 24 B 5. 35 B

book value:  0. 39   13. 42   27. 58  
price/book:  1. 54   2. 67   -3. 06  
operating margins:  0. 00 % -691. 69 % -99. 65 %
EBITDA margins:  0. 00 % 12. 76 % 20. 68 %
profit margins:  0. 00 % 9. 80 % 9. 36 %
gross margins:  0. 00 % 42. 57 % 53. 92 %

1-yr max volatility:  123. 12 % --- ---
1-yr mean volatility:  0. 33 % 0. 05 % 0. 08 %

1-yr EPS:  -1. 44   2. 98   3. 81  
forward EPS:  -0. 23   4. 58   6. 86  
P/E:  -0. 42   17. 33   25. 71  
forward P/E:  -2. 70   -44. 22   11. 00  
PE/G:  0. 01   -2. 22   0. 51  
growth:  -67. 51 % 94. 22 % 28. 45 %
earnings high:  -0. 00   1. 15   1. 57  
earnings avg:  -0. 00   0. 90   1. 44  
earnings low:  -0. 00   0. 61   1. 32  
revenue high:  -0. 00   2. 74 B 10. 73 B
revenue avg:  -0. 00   2. 65 B 10. 55 B
revenue low:  -0. 00   2. 54 B 10. 35 B
return on assets:  -51. 90 % -1. 39 % 5. 03 %
return on equity:  -114. 99 % -7. 64 % 6. 55 %

beta (1yr vs S&P500):  0. 90   1. 25   0. 95  
sharpe (1yr):  0. 38   0. 55   1. 18  

held % insiders:  6. 88 % 6. 44 % 3. 73 %
held % institutions:  11. 34 % 79. 27 % 68. 99 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-03-25 : OGEN
.        + 0 =             0 :: INITIAL WEIGHT
.   + 39.073 =        39.073 :: inverse volume-to-price addition
.    + 36.94 =        76.013 :: spline projection addition
.   - 31.231 =        44.782 :: add/subtract for performance
.    x 1.124 =        50.347 :: 13 weeks' performance factor
.    x 0.579 =        29.162 :: one-year gains+dividend factor
.    x 1.437 =        41.906 :: industry recommendation factor
.    x 2.068 =        86.681 :: symbol recommendation factor
.    x 0.995 =        86.231 :: return on assets factor
.    x 0.989 =         85.24 :: return on equity factor
.     x 2.15 =       183.283 :: current ratio factor
.    x 1.062 =       194.578 :: quick ratio factor
.    x 1.267 =       246.589 :: short ratio factor
.    x 2.015 =       496.982 :: price-to-book factor
.    x 1.017 =       505.679 :: debt-to-equity factor
.    x 2.169 =      1096.908 :: P/E weight
.    x 2.209 =      2423.025 :: PE/G factor
.     x 1.41 =      3415.367 :: beta factor
.    x 0.379 =      1293.173 :: sharpe factor
.    x 1.601 =      2070.128 :: target low factor
.     x 1.19 =      2464.293 :: target mean factor
.    x 1.057 =      2605.058 :: target high factor
.    x 1.107 =       2884.61 :: industry 12-weeks return
.    x 0.902 =      2603.115 :: "drift" penalty 1 days ago
.    x 0.669 =      1740.217 :: "drift" penalty 3 days ago
.    x 0.943 =      1641.152 :: "drift" penalty 5 days ago
.    x 0.603 =       989.002 :: overall "drift" factor
.    x 0.333 =       329.668 :: largest single-day jump factor
.     x 0.06 =        19.883 :: low price factor
.    x 0.999 =         19.87 :: factor hist industry gain for week 12
.   cubeRoot =         2.709 :: reduced to standardize
.                      2.709 :: FINAL WEIGHT for NYSEAMERICAN:OGEN


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org